The natural history of 21-hydroxylase autoantibodies in autoimmune Addison’s disease

in European Journal of Endocrinology
View More View Less
  • 1 A Wolff, Department of Clinical Science, University of Bergen, Bergen, Norway
  • 2 L Breivik, Department of Clinical Science, University of Bergen, Bergen, Norway
  • 3 K Hufthammer, Seksjon for forskning og innovasjon, Haukeland University Hospital, Bergen, Norway
  • 4 M Grytaas, Department of Medicine, Haukeland University Hospital, Bergen, Norway
  • 5 E Bratland, Department of Clinical Science, University of Bergen, Bergen, Norway
  • 6 E Husebye, Department of Clinical Science, University of Bergen, Bergen, Norway
  • 7 B Oftedal, Department of Clinical Science , University of Bergen, Bergen, Norway

Correspondence: Eystein Sverre Husebye, Email: eystein.sverre.husebye@helse-bergen.no

Background: The most common cause of primary adrenal failure (Addison’s disease) in the Western world is autoimmunity characterized by autoantibodies against the steroidogenic enzyme 21-hydroxylase (CYP21, 21OH). Detection of 21OH-autoantibodies is currently used for etiological diagnosis, but how levels of 21OH-antibodies vary over time is not known.

Setting: Samples from the national Norwegian Addison’s Registry and Biobank established in 1996 (N=711). Multi-parameter modelling of the course of 21OH-antibody indices over time.

Results: 21OH antibody positivity is remarkably stable, and >90% of the patients are still positive 30 years after diagnosis. Even though the antibody levels decline with disease duration, it is only rarely that this downturn reaches negativity. 21OH-antibody indices are affected by age at diagnosis, sex, type of Addison’s disease (isolated vs. autoimmune polyendocrine syndrome type I or II) and HLA genotype.

Conclusion: 21OH-autoantibodies are reliable and robust markers for autoimmune Addison’s disease, linked to HLA risk genotype. However, a negative test in patients with long disease duration do not exclude autoimmune etiology.

If the inline PDF is not rendering correctly, you can download the PDF file here.

 

     European Society of Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 96 96 80
PDF Downloads 87 87 72